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Abstract
Background: In cystic fibrosis (CF) the exact ion composition of the airway surface fluid is still debated and it is not clear if
it differs from healthy subjects. The air that we exhale contains small droplets, which are generated by shear forces from the
airway surface fluid and very likely mirror its ion composition. We hypothesized that differences between CF-patients and healthy
controls would be reflected by differences in their exhaled air. Methods: In nasally collected exhaled breath condensate from 20
children and young adults with cystic fibrosis and 20 healthy subjects, the elements and anions were determined by optical
emission spectroscopy and ion-exchange chromatography. Results: The concentrations of the major components Na and Cl didy
not differ, Zn was higher and NO was lower in CF-patients. During a given time period, CF-patients produced a slightly largery3
volume of breath condensate and they exhaled more Na, K and Zn. Fluoride was detected in half of all samples, whereas copper,
iron, magnesium, phosphorus and sulfur were present only sporadically, with no differences. Conclusions: These data detail the
composition of exhaled breath condensate and suggest a similar Na and Cl concentration in CF-airway surface fluid as iny
healthy subjects.
 2003 European Cystic Fibrosis Society. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Cystic fibrosis (CF) is the most common fatal inher-
ited disease in Caucasians. Mutations in the gene encod-
ing for a protein called the cystic fibrosis transmembrane
conductance regulator (CFTR) lead to the clinical man-
ifestations of the disease w1x. These include chronic lung
disease, exocrine pancreatic insufficiency, CF-related
diabetes and chronic liver disease. The CFTR belongs
to a group of transmembrane proteins and mainly acts
as a cAMP regulated chloride channel. This channel
controls the secretions in the sweat glands, the respira-
tory, gastrointestinal and reproductive tracts.
The exact ion composition of the airway surface
fluids (ASF) in the respiratory tract is still debated,
mainly due to sampling difficulties, e.g. invasiveness to
obtain a representative volume of the thin film of the
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ASF without disturbing the system. The volumes sam-
pled by filter paper or other capillary methods are
generally much larger than the fluid volume in the
normally less than 100 mm thick ASF film. Even if the
concentrations cannot be easily determined correctly, it
would be important to know if there are differences
between CF patients and healthy controls. Utilizing the
filter paper and micro-pipette sampling methods, in vivo
measurements of the trachea and bronchi have suggested
a higher chloride (Cl ) concentration of ASF in CFy
w2,3x. Whereas no differences were observed by one
group w4x, another found somewhat (approx. 30%) lower
Cl concentrations in CF patients with significanty
inflammation in their bronchial tract, but not in those
without, where also no difference was found w5x. The
concentrations of sodium (Na) were not different
between controls and CF patients in three studies w3–
5x. Recent results with the technique of non-invasive in
vivo fluorescence measurements, demonstrated the same
ASF concentrations of Na and Cl in the trachea ofy
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Fig. 1. Schematic representation of the device used to collect nasal
exhaled breath condensate. Nasal prongs, as routinely used for oxygen
delivery, are adjusted to the subject. Then suction, i.e. a negative pres-
sure is applied and the recovered exhaled air is condensed in a cold
trap.
normal mice and cystic fibrosis (CFTR-null) mice.
Similar concentrations were found in ex vivo fragments
of normal human bronchi w6x.
In this study, we undertook an alternative approach to
gain information on the abundance and on the spectrum
of ions and elements in normal subjects and CF patients.
The air that we exhale is saturated with water vapor and
also contains significant numbers of small droplets of
salty fluid w7x. Particles with a diameter of less than 1
mm are preponderant w7x. These droplets are believed to
be generated by high velocity air flow, which creates
shear forces that overcome the adhesion of the fluid to
the airway surfaces. Thus, it is very likely that the ion
composition and volume of the exhaled droplets mirror
the corresponding characteristics of the ASF. We hypoth-
esized that potential differences in ion concentration and
volume of ASF between CF-patients and healthy con-
trols, would be reflected by differences of the respective
variables in exhaled air, which can be collected as breath
condensate. However, two major technical problems
exist. Sufficient material has to be collected in a reason-
able time and a contamination with saliva must be
avoided, as the latter contains high concentrations of
Na, Cl and potassium (K) in the mM range w8x. Thesey
two issues were overcome with the help of a simple
sampling technique that readily collects several millili-
ters of nasally exhaled air condensate in humans of all
ages, non-invasively, touch free and not necessitating
cooperation w9x. This is achieved by nasal prongs that
are positioned below the nares without coming into skin
contact and through which a fraction of the exhaled
breath is suctioned and then condensated in a cold trap
(Fig. 1). Here we report the elemental and ion compo-
sition of breath condensate in patients with CF and
healthy controls.
2. Methods
2.1. Subjects
Twenty patients with CF, diagnosed by positive sweat
tests, genetic analysis and typical clinical presentation
with a median age of 19 years (14, 25) range 7–30
years in a clinically stable condition were assessed
during a routine clinical visit. The patients were com-
pliant with standard treatment, including chest physio-
therapy and inhaled therapy (median FEV1, was 55 (40,
76)% of predicted, FVC 73 (64, 86)% of predicted.
Nineteen of the patients had DF508 (14 homozygous, 5
heterozygous (G542X, R553X, 3 unknown)), in one
patient the mutation was not identified. Sixteen of the
patients were chronically infected with Pseudomonas
aeruginosa. All patients had a free nasal passage for air
and one of the 20 patients with CF had nasal polyps,
which were removed last 1 year ago.
Twenty healthy subjects with a median age of 22.5
years (14, 26) range 7–28 years were assessed for
comparison. In a pilot study in four of these subjects
repeatability of the collection and measurements was
assessed by consecutive measurements on three separate
days. Within subject standard deviation, as a measure
of reproducibility in this small set of subjects was 12.6
mmolyl for Na (median of these measurements 28.6
mmolyl) and 9.8 of Cl (median of these measurementsy
5.7 mmolyl), suggesting some degree of variation w10x.
This was likely to be associated with the collection of
the EBC and the biological variation of the content of
elements and ions, as the reproducibility of Na and
Cl standards in the relevant concentration range wasy
-5%. The power was 80% to detect differences for Na
and Cl in the magnitude of these standard deviationsy
between two groups of subjects if 20 subjects were
included in each group w11x.
The study was approved by the local ethical commit-
tee and informed consent was given by all participants.
2.2. Collection of nasally exhaled air condensate and of
sweat
Breath condensate was collected 12 h after the last
inhalation therapy by condensation of the water vapor
from exhaled air in a cold trap which was made by
three 50 ml polypropylene tubes almost completely
submerged in water frozen at y20 8C, generating a
temperature of y5 8C and connected by 7 mm inner
diameter tubing (Fig. 1). One side of the cold trap was
connected to an electric pump (Laborport N 811 KN.18y
5, KNF Neuberger, Freiburg, Germany, 11 lymin) and
the other side was connected to nasal prongs usually
used for oxygen delivery (T 1012, Trident, Germany).
The nasal prongs were positioned ‘touch free’ in front
of the nostrils and breath condensate was collected for
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Table 1
Concentrations of Na, Cl , K, Ca, Zn and NO in exhaled breathy y3
condensate of healthy controls and patients with cystic fibrosis
Cystic fibrosis Healthy controls P
Na 26.9 (14.3, 50.1) 14.1 (10.9; 24.6) 0.1112
Cly 24.2 (14.5, 33.2) 16.8 (11.6; 24.7) 0.1596
Ca 13.1 (8.2; 16.0) 6.5 (4.5; 16.6) 0.1076
K 15.3 (10.3; 23.2) 3.8 (0.0; 14.8) -0.05
Zn 3.2 (1.6; 6.4) 1.7 (1.1; 2.4) 0.0193
NOy3 4.2 (2.5;8.5) 16.0 (7.2; 23.9) -0.004
All data are median and 25. 75 percentile (interquartile range) from
20 controls and 20 patients with CF and given as mmolyl. Values
below the lower level of detection were found for K in four CF
patients and in 10 controls, in one control Na was below the lower
level. Cl and Ca were always detected. Comparisons were made byy
Mann–Whitney test.
2 or 4 h of quiet nasal breathing. The amount of exhaled
breath condensate collected was determined by weighing
the pre-weighed polypropylene tubes and the contents
of the three tubes were always pooled. The collecting
system was rinsed with 0.5 ml of water for 1 h and the
elements and ions recovered were evaporated to dryness
and also included in the analysis.
In order to avoid differences between CF patients and
controls in the humidification of the in- or exhaled air,
we took great care to randomly mix CF patients and
controls on the same days.
2.3. Orally exhaled breath condensate
In six healthy subjects, orally exhaled breath conden-
sate was also collected by breathing into polyethylene
tubing of 11 mm internal diameter and 100 cm length
which was submerged almost completely in water frozen
at y20 8C, generating a temperature of y5 8C through-
out the collection period. One side of the tubing was
open and the other was connected to a mouth-piece
connected to a T-piece with ex- and inspiratory valves.
The latter served as a saliva trap. Breath condensate
with this mode was collected for 2 or 4 h of quiet oral
breathing and the concentrations of the cations were
determined.
2.4. ICP-SIM-optical-emission spectroscopy
Elements (calcium (Ca) copper (Cu), iron (Fe), K,
magnesium (Mg), phosphorus (P), sulfur (S), Na and
zinc (Zn) were measured by ICP-SIM- (Inductively-
Coupled-Plasma-Simultaneously) optical emission spec-
troscopy (JY-70 PLUS, Jobin-Ivon Instruments S.A.,
USA) in 5 ml of exhaled breath condensate or 10–70
ml of sweat diluted to this volume, as described previ-
ously w12x. Briefly, an aerosol of the samples is gener-
ated and injected into an argon plasma (approx. 8000
K, flow rate 15 lymin) and the emission spectra are
quantified by comparison to standards (XSPEXF-95 and
-96, Spex Industries, Edison, USA).
2.5. Ion-exchange chromatography
The anions fluoride (F ), chloride (Cl ), nitritey y
(NO ), nitrate (NO ), phosphate (PO ) and sulfatey y 3y2 3 4
(SO ) were separated in 0.5 ml samples by ion2y4
exchange chromatography (4000i, Dionex, Sunnyvale,
USA). After separation on AS4A-SC column (Dionex,
Sunnyvale, USA) the anions were quantitated by con-
ductance measurements and comparison to the appropri-
ate standards.
The lower limit for the detection of Na, K, Ca and
Cl was 4.7 mmolyl for Na, 6.1 mmolyl for K, 2.4y
mmolyl for Ca and 2.4 mmolyl for Cl , that for Zn wasy
1.4 mmolyl and for NO 0.06 mmolyl. The limits fory3
the other elements or ions are given in Table 2. The
background levels of element and ion concentrations in
5 ml of sterile water (Pharmacia and Upjohn, Freiburg,
Germany) and 1 h soaking of the collecting system
were below the lower limits of detection for Cu, Fe, K,
Mg, Na, P, S, F , Cl , NO , PO and SO (ns5).y y y 3y 2y2 4 4
For Ca, a median of 6.2 mmolyl, range 5.6–7.7 was
measured, for Zn a median of 1.5 mmolyl, range 1.4–
1.7 and for NO a median of 3.4 mmolyl, range 2.5–y3
5.1 (ns5) was obtained. These values were routinely
subtracted from the concentrations and amounts meas-
ured in the exhaled breath condensate.
2.6. Statistics
All values are given as medians and interquartile
range (25 and 75 percentile) in brackets of 20 subjects
in each group. The repeatability of three repeated meas-
urements was assessed from the results of a one-way
analysis of variance and expressed as the within subject
deviation calculated by division of the square root of
the pooled within subjects sum of squares divided by
its degrees of freedom w10x. The two groups of subjects
were compared by the two sided, unpaired Mann–
Whitney U-Test. P-0.05 was considered significant
w11x.
3. Results
3.1. Concentration of elements and anions in exhaled
breath condensate
Exhaled breath condensate contained Na, K, Ca and
Cl at mM concentrations (Table 1). Also, Zn andy
NO were regularly present. In contrast, F , NO , Mgy y y3 2
and S were found less frequently and SO , PO , P,2y 3y4 4
Fe and Cu were only sporadically detected (Table 2).
CF-patients had significantly higher concentrations of
K. Na, Cl and Ca concentrations did not significantlyy
differ between the two groups (Table 1). These data did
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Table 2
Detection and concentrations (mmolyl) of trace ions in exhaled breath condensate of CF-patients and controls
Element or Lower limit of CF patients (ns20) Controls (ns20)
ion detection
Frequency of values Median Individual values above Frequency of values Median Individual values above(mmolyl)
above lower limit (mmolyl) lower limit of detection above lower limit (mmolyl) lower limit of detection
of detection (mmolyl) of detection (mmolyl)
Cu 0.06 0y20 0.00 1y20 0.00 0.11
Fe 0.06 0y20 0.00 1y20 0.00 0.13
Mg 2.8 5y20 0.00 11.6, 9.6, 10.9, 10.6, 7.8 6y20 0.00 7.8, 18.9, 8.0, 6.2, 4.4, 6.4
P 4.9 1y20 0.00 55.8 0y20 0.00
S 4.0 6y20 0.00 13.2, 10.5, 7.4, 11.4, 13.4, 30.8 3y20 0.00 14.2, 12.8, 9.2
Fy 4.3 11y20 6.16 7.9, 14.4, 18.8, 6.4, 5.9, 19.8, 11y20 5.66 17.3, 25.7, 32.3, 5.7, 23.6, 22.7,
16.2, 10.8, 15.6, 10.2, 6.9 13.4, 40.3, 8.1, 22.7, 5.6
NOy2 1.9 7y20 0.00 4.5, 4.3, 3.9, 5.1, 6.0, 4.6, 4.4 3y20 0.00 4.9, 5.5, 4.9
PO3y4 2.1 1y20 0.00 16.7 0y20 0.00
SO2y4 0.9 3y20 0.00 4.6, 9.7, 5.8 3y20 0.00 2.7, 9.4, 5.3
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Fig. 2. Individual values of the volume of exhaled breath condensate
collected over a 2-h period. Differences between the two groups were
calculated by the 2-sided Mann–Whitney-test.
Table 3
Amounts (nmol) of Na, Cl , K, Ca, Zn and NO in exhaled breathy y3
condensate of CF-Patients and controls exhaled over a 2 h collection
period
Cystic fibrosis Healthy controls P
Na 157.9 (82.4; 301.1) 89.6 (55.6; 132.3) -0.05
Cly 127.9 (82.0; 205.5) 80.6 (60.1; 130.7) 0.0811
Ca 71.1 (34.9; 108.4) 32.3 (17.9; 74.2) 0.0602
K 91.6 (52.5; 145.6) 15.4 (0.0; 75.9) -0.05
Zn 15.9 (8.0; 35,4) 7.4 (4.7;11.6) -0.01
NOy3 18.5 (9.7; 35.3) 92.1 (33.5;120.5) -0.01
All data are median and 25. and 75. percentile (interquartile range)
from 20 controls and 20 patients with CF. Comparisons were made
by Mann–Whitney test.
not vary with age, sex, FEV or status of Pseudomonas1
infection (data not shown). Zn levels were consistently
higher in CF-patients (3.2 (1.6, 6.4) vs. controls 1.7
(1.1, 2.4) Ps0.0193), whereas NO was approximatelyy3
four times lower (CF 4.2 (2.5, 8.5) vs. controls 16.0
(7.2, 23.9), P-0.004). For the other elements and ions
no significant differences were detected (Table 2).
3.2. Volume and amounts of elements and anions exhaled
and collected in breath condensate
As we used a fixed sampling period of tidal breathing
of the exhaled breath condensate, we also compared the
volumes of the condensate collected. The volume
exhaled by CF patients (6.1 (5.6, 7.3) mlyh) was
significantly higher than that of controls (5.3 (4.9, 6.1)
mlyh, P-0.02, Fig. 2). The volume collected did not
correlate with age or FEV (data not shown).1
Based on these findings we calculated for each indi-
vidual subject the absolute amounts of elements or
anions exhaled. The amounts of Cl and Ca werey
marginally increased in CF patients (Table 3). Na and
K were significantly increased (Table 3), however, as
indicated in the legend to Fig. 1, K was not regularlyq
detected in all samples. The increased concentration of
Zn in breath condensate translated into increased
amounts exhaled by CF patients compared to controls
(CF 15.9 (8.0, 35.4) nmoly2 h vs. controls 7.4 (4.7,
11.6) nmoly2 h, P-0.01). Despite the higher volume
of exhaled air condensate in CF patients than in controls,
the amount of NO was still significantly lower in CFy3
patients (18.5 (9.7, 35.3) nmoly2 h vs. controls 92.1
(33.5, 120.5) nmoly2 h, P-0.01). For all other elements
and ions no differences between the two groups of
subjects were observed.
4. Discussion
Nasally exhaled air condensate regularly contained
several ions and elements, among which Na and Cly
were the principal components. Ca, K, Zn and NOy3
were also abundant and a comparison to serum indicated
that the composition of EBC is not just a reflection of
passively transudated components, but differentially con-
trolled. In addition, other elements and ions were detect-
ed at variable frequency.
CF patients and controls did not differ in the major
components of EBC, e.g. they had the same concentra-
tions of Na and Cl . A difference, e.g. for Na in they
range of the standard deviation between the two groups
would have been detected with a power of 80%. There
were, however, also significant differences between the
two groups of patients studied. CF patients had higher
concentrations of K and Zn, and lower NO concentra-y3
tion. The volume of the exhaled air condensate collected
over a given period of time was also significantly higher
in CF patients.
The technique used here to obtain the data on the
fluids and elemental composition of the ELF was essen-
tially non-invasive and thus very unlikely to disturb the
in situ situation within the airways by sampling. There-
fore, these results are strong, albeit indirect evidence,
for the extent of similarities and differences in the
airway fluid content and elemental composition between
controls and CF patients that can be expected. A
comparison of the values in exhaled breath condensate
with those obtained by direct sampling techniques, e.g.
the filter paper method, is difficult. The solute concen-
trations are almost a 1000-fold lower in breath conden-
sate, demonstrating substantial dilution of the ‘salty
droplets’ in exhaled air w7x by the water saturated
exhaled breath that also condenses in the cold trap.
Several factors may account for the small but signif-
icant increase in volume of exhaled breath condensate
collected in CF patients (Fig. 2). Assuming that the
droplets suspended in the exhaled air are generated by
shear forces that overcome the adhesion of the fluid to
the airway surfaces, such events are much more likely
to occur in CF lungs with remodeled airways from
chronic inflammation. In addition, the significantly
increased airway surface that is covered by mucus plugs
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also increases the likelihood of turbulent air flow, which
generates shear forces and droplets. Na and Cl concen-y
trations, as well as the overall osmolarity, i.e. the
calculated sum of all species assessed was not different
between CF-patients (92.2 mosmolyl (63.8; 136.1) and
controls (81.0 mosmolyl (56.1; 107.3); Ps0.456), mak-
ing osmotic forces, i.e. different amounts of solutes,
unlikely to be responsible for the observed differences
in the volumes of exhaled breath condensate collected.
NO has been previously measured in EBC fromy2
patients with CF spectro-photometrically by the Griess
reaction and was found elevated in some reports w13–
15x. However, in 50% of the control samples in the
study of Cunningham et al., NO was below the levely2
of detection with the method used w14x. Others found
an unchanged level w16x which is in agreement with our
results. In the latter study also NO was measuredy3
indirectly, after reduction to NO and no differencesy2
were found. We found a reduced level of NO in oury3
group of stable CF patients, using a method that directly
assesses NO . These results are in agreement with ay3
relatively minor role of nitric oxide in oxidative lung
injury in CF w17,18x.
Interestingly, Zn was consistently present in nasally
exhaled breath condensate at concentrations of approxi-
mately 1y10 of those of Na and it was increased in CF-
patients (Tables 1 and 3). There have been extensive
studies on Zn homeostasis in CF-patients demonstrating
significant fecal losses in young infants w19x. Although
twice the amount of Zn was lost in our CF-patients
compared to controls by exhaled air, the calculated loss
of approximately 1 mg of Zn per day is unlikely to
substantially contribute to overall Zn homeostasis with
an average mean net absorption of 190"160 mgyd w19x.
Sources of Zn in the airways may be sloughed off
epithelial cells and possibly secreted metalloenzymes
w20x. For both, Zn and NO the interpretation of they3
results has to bear in mind that the compounds were
found at a certain background level in the collection
system (see 2.5).
Lastly, we were interested in the presence of other
trace ions or elements in EBC. The sensitivity of the
methods used was relatively high and is indicated in the
methods section and in Table 2. None of the trace
compounds assessed was consistently detectable at suf-
ficient concentrations, except for F , which was foundy
in approximately 50% of both the controls and the CF-
patients with no difference between the two groups
(Table 2). The function of F in the airways is noty
clear, but F has been suggested to play a stimulatoryy
role in CFTR Cl -channel activity w21x.y
The absence of substantial amounts of phosphate and
sulfate also support the view that exhaled breath con-
densate collected by this method which avoids saliva
contamination, does not contain significant amounts of
DNA or mucins. This is in agreement with our previous
study where we detected larger proteins only in nmolar
amounts w22x.
To estimate how the nasally exhaled breath condensate
used throughout this study compares to the one collected
by the oral collection method, in six subjects paired
samples were obtained with both methods and assessed
for cations. The concentrations of the majority of the
ions (Na, Ca, Mg, Fe, P, S) were identical with both
methods of collection. Of interest, K (nasal breath
condensate 30.7 (11.5; 41.2) mmolyl vs. oral breath
condensate 9.1 (2.7; 15,7) mmolyl, Ps0.0017) and
Zn (nasal breath condensate 2.9 (1.8; 4.1) mmolyl vs.-
oral breath condensate 0.1 (0; 0.2) mmolyl, Ps0.0017)
were higher in nasal condensate suggesting differences
related to the collection methods used or in the com-
partments being sampled. However, overall the data
indicated very similar degrees of dilution of the particle
droplets exhaled, resulting in similar levels of concen-
trations for both types of exhaled breath condensate.
Exhaled breath condensate solute concentrations may
vary substantially between subjects and also intra-indi-
vidually, as indicated in Section 2 and previously by
others w23x and us w9x. Additionally, differences in other
as yet unknown factors, i.e. the analytical methods,
specific equipment and factors related to the subject and
environmental conditions, are likely to influence the
results obtained. In the study by Effros et al. w23x more
than 10-fold higher mean concentrations of Na, K, Cly
were observed compared to the present study. In addi-
tion, to the factors mentioned above, this may be related
to differences in the tubing length and thickness w23x,
duration of the collection period and the analytical
methods used. Importantly, in the study by Effros et al.
illustrating the variability of Na, half of the individual
values shown were below 50 mmolyl, i.e. median Na
concentration was much lower than mean Na, due to
non-normal distribution of the values. Other studies
have reported an even larger range for other variables,
e.g. H O in breath condensate may span from 0.000012 2
mM w24x to 0.74 mM w25x in healthy adults. Standards
for the collection and analysis are highly desirable, but
unfortunately have not yet been proposed and up to that
we will mainly have to confine within study
comparisons.
Taken together our results on Na, K and Cl supporty
the view that there are no major differences in the ion
concentration of the ASF between CF and control lungs.
The amount of water and several solutes lost during
breathing appears larger in CF-patients. This technique
can be applied in all age groups and opens a way to
assess the internal milieu of the lungs non-invasively
and very likely without disturbance. Serial measure-
ments are feasible and may allow the quantitation of the
effects of therapeutic modulators of CFTR function.
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